<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02932865</url>
  </required_header>
  <id_info>
    <org_study_id>SemiFluid</org_study_id>
    <nct_id>NCT02932865</nct_id>
  </id_info>
  <brief_title>Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility</brief_title>
  <acronym>SemiFluid</acronym>
  <official_title>Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Men are recruited to collect seminal plasma samples and serum samples from men with
      azoospermia, men receiving medical treatment of infertility and men attending semen analysis.
      MicroRNA (miRNA) and PiWi-interacting RNA (piRNA) are analyzed for all of the groups to find
      potential differences. Steroid hormones are analyzed by liquid chromatography-tandem mass
      spectrometry.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Azoospermic men attending microdissection testicular sperm extraction (MD-TESE) are group A.
      Second group (B) is the men with poor semen quality, who are treated with aromatase
      inhibitor, antiestrogen or human choriogonadotropic hormone (HCG) to improve semen quality.
      Third group (C) consists of men submitting semen analysis. The intended number of
      participants is 60, 60 and 100 men, respectively.

      Seminal plasma and serum samples are collected and miRNA and piRNA are analyzed. Steroid
      hormones are analyzed by liquid chromatography-tandem mass spectrometry. The participants are
      given a physical examination and testicular ultrasound. The primary aim of this study is to
      develop a tool to better estimate the sperm recovery rate (SRR) of azoospermic men scheduled
      for MD-TESE. Since no data have been published presenting miRNA and piRNA levels in men with
      normal semen, a secondary aim is to describe the levels of miRNA and piRNA in unselected men.
      Third part of this study aims to find if medical treatment improving semen parameters affects
      miRNA ja piRNA findings.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>miRNA and piRNA according to sperm recovery in MD-TESE</measure>
    <time_frame>Two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess miRNA and pRNA changes with hormonal treatment</measure>
    <time_frame>two years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Describe miRNA and piRNa levels in seminal plasma of unselected men</measure>
    <time_frame>two years</time_frame>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Infertility, Male</condition>
  <arm_group>
    <arm_group_label>MD-TESE (A)</arm_group_label>
    <description>Azoospermic men, MD-TESE operation (standard treatment). Semen sample, serum sample and physical examination with testicular ultrasound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subfertile men (B)</arm_group_label>
    <description>Subfertile men receiving medication (standard treatment). Semen sample, serum sample and physical examination with testicular ultrasound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control (C)</arm_group_label>
    <description>Control group, men scheduled for semen analysis. Semen sample, serum sample and physical examination with testicular ultrasound.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Semen sample Serum sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Men contacting the fertility clinic in Turku University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ability to produce semen sample

        Exclusion Criteria:

          -  Cognitive impairment

          -  Inadequate language skills for informed consent
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antti Perheentupa, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Turku</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rauni klami, MD</last_name>
    <phone>358407286874</phone>
    <email>rauni.klami@tyks.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antti Perheentupa, MD, PhD</last_name>
    <phone>+358445349025</phone>
    <email>antper@utu.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rauni Klami, MD</last_name>
      <phone>+358407286874</phone>
      <email>rauni.klami@tyks.fi</email>
    </contact>
    <contact_backup>
      <last_name>Antti Perheentupa, MD, PhD</last_name>
      <phone>+358445349025</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2016</study_first_submitted>
  <study_first_submitted_qc>October 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2016</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>azoospermia</keyword>
  <keyword>male fertility</keyword>
  <keyword>MD-TESE</keyword>
  <keyword>miRNA</keyword>
  <keyword>piRNA</keyword>
  <keyword>male infertility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

